On Jun 30, 2021 Intellia Therapeutics (NTLA) announced a public offering of nearly 4.14 million shares and gained $600,000,000 by 2nd July, 2021.

About the company: Intellia Therapeutics is located in Cambridge, MA, United States. Intellia Therapeutics is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system invented by Jennifer Doudna (with colleagues at University of California, Berkeley) and Virginijus Šikšnys (with colleagues at Vilnius University). The company has partnerships with Novartis and Regeneron and is backed by Atlas Venture and Novartis.

Company website: intelliatx.com